2017 Events

In 2017, we continue to explore the interactions of research, engineering, and the impact of information science on medical progress. As a reference, the colors above highlight the key themes to be addressed in each event.

Throughout the year we will address aspects of Precision Medicine, which is informing most of the industry today.  You are hereby invited to join us, share your expertise, and find new collaborators. Registration opens soon. Register for Updates to receive notices!

Call for Abstracts is open, Click Here.
Feel free to contact us directly with any questions or comments jgere@biopharmaresearchcouncil.org          
Looking into the past? Click Here  

2017 Innovations Clinical Trials - Header.png

Data collection in clinical trials has been converting to all-electronic formats, creating an opportunity for innovation in sensors, remote video connections, and apps for mobile devices.  In turn, Social Media tools in clinical trials are opening new opportunities for pharma clinical teams, CROs, and IT system professionals to gather and access data. For example, by working with CROs and patient groups, pharma companies and principal investigators are able to accelerate identifying, engaging, and enrolling subjects.

Highlights of discussions will include features needed to lower barriers to adoption of tools, such as ease of use and clear protection of privacy and security.

Moving a drug from discovery to process engineering requires coordination among multiple disciplines.
In this session, experts will share their knowledge and lessons learned from historical and current perspectives.  

Discussions will include the chemistry and biology used to develop reagents, cell lines, isolation and purification techniques, as well as the analytical validation critical for realizing optimized pathways for biologics production. Presentations will cover emerging technologies to accelerate and improve current methods.  

These materials and tools are the basis for further development of the continuous and end-to-end processes required today.

2017 IOMT III - Header.jpg

Hospitals, houses, ambulances, and doctor’s offices are already undertaking significant efforts to integrate sensors, video technology, wireless readouts, and analyses to monitor a patient’s welfare. Today’s medical device engineering is focused even more on innovative applications and easier usability to accelerate this process.

After a morning of key discussion on these opportunities, an afternoon session will feature experts in cybersecurity to weigh in on questions concerning the privacy and security of connected devices, including hospital equipment, implants, wearables, and related databases.

With the emergence of Precision Medicine, e-Health, and the expanding impact of data to drive clinical trial design and therapeutic decisions, the ability to work in partnerships and share information has become more vital.

Now in its sixth year, this Symposium provides a platform to share knowledge being developed across the region’s research centers, including breakthroughs that are opening the doors to more effective, better targeted treatment for patients.

Participants will include innovators from academic, industry, and government labs, who will introduce potential collaborators to each others’ diverse research and development.

Industry momentum has started to move toward portfolios that include biologics, vaccines, and cell-based therapies. In this full-day Expo, we address the changes that drive new technologies and tools

Engineering tomorrow’s drug manufacturing lines requires integration of lessons learned to build continuous processing lines. This requires a unique coordination between researchers and process engineers.

Plenary sessions and Training Workshops will include exploration of emerging solutions such as single use approaches. and lessons learned from existing continuous process lines.